ContractAntibody Fragments Contract Manufacturing Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations
*CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *.
AGREEMENT DATED 18th December, 2002 REVOLVING CREDIT FACILITY for CELLTECH GROUP PLC arranged by THE ROYAL BANK OF SCOTLAND PLC ALLEN & OVERY London ALLEN & OVERY LondonRevolving Credit Facility • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • Delaware
OPTION AGREEMENT between PHARMACIA AB and CELLTECH PHARMACEUTICALS LTD. Dated as of July 23, 2002Option Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • New York
This OPTION AGREEMENT (the “Option Agreement”) is entered into as of July 23, 2002 by and between Pharmacia AB, a Swedish corporation, (“Pharmacia”) and Celltech Pharmaceuticals Ltd., an English corporation (“Celltech”).
CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN *. AGREEMENT BETWEEN PHARMACIA AB AND CELLTECH PHARMACEUTICALS LTD. DATED July 23, 2002License Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • New York
This Agreement (the “Agreement”) is entered into as of July 23, 2002 (the “Effective Date”), by Pharmacia AB, a Swedish corporation (“Pharmacia”) and Celltech Pharmaceuticals Ltd., an English corporation (“Celltech”).
THIS AGREEMENT is made the day of 2002 BETWEEN:Overdraft Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • London
COLLABORATION AND LICENSE AGREEMENT By and Between PHARMACIA & UPJOHN COMPANY and CELLTECH CHIROSCIENCE LIMITEDCollaboration and License Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • London
This Collaboration and License Agreement dated the 28th day of February, 2001 (the “Execution Date”) is by and between Pharmacia & Upjohn Company, a corporation organized and existing under the laws of the State of Delaware, USA and having a place of business at 100 Route 206 North, Peapack, New Jersey 07977 USA (“Pharmacia”), and Celltech Chiroscience Limited, a corporation organized and existing under the laws of England and having its principal office at 216 Bath Road, Slough, Berkshire SL1 4EN UK (“Celltech”).
EUROPE ASSET PURCHASE AGREEMENT BETWEEN PHARMACIA AB AND CELLTECH PHARMACEUTICALS LTD. DATED AS OF SEPTEMBER 2, 2002Asset Purchase Agreement • June 30th, 2003 • Celltech Group PLC • Pharmaceutical preparations • New York
This Europe Asset Purchase Agreement (the “Agreement”) is entered into as of September 2, 2002 (the “Effective Date”), by Pharmacia AB, a Swedish corporation (“Pharmacia”) and Celltech Pharmaceuticals Ltd., an English corporation (“Celltech”).
